Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
作者信息
Reznik Sandra, Tiwari Amit, Ashby Charles
机构信息
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York City, USA; Departments of Pathology and Obstetrics and Gynecology and Women's Health, Montefiore Medical Center/Albert Einstein College of Medicine, Queens, New York City, USA.
Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA; Department of Cancer Biology, College of Medicine and Life Sciences, University of Toledo, Toledo, Ohio, USA.
出版信息
Bosn J Basic Med Sci. 2022 Jul 29;22(4):660-664. doi: 10.17305/bjbms.2021.6901.
Abstract
摘要
相似文献
1
Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?静脉注射免疫球蛋白：一种治疗新冠病毒感染后急性后遗症的潜在疗法？
Bosn J Basic Med Sci. 2022 Jul 29;22(4):660-664. doi: 10.17305/bjbms.2021.6901.
2
Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection.用于治疗新型冠状病毒感染急性症状和急性后遗症的口服抗病毒药物。
Lancet Infect Dis. 2024 Oct;24(10):1066-1067. doi: 10.1016/S1473-3099(24)00258-5. Epub 2024 May 3.
3
Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with intravenous immunoglobulin: 'Killing 2 birds with one stone'.静脉注射免疫球蛋白治疗中毒性表皮坏死松解症合并严重急性呼吸综合征冠状病毒2（COVID-19）：“一石二鸟”
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e97-e98. doi: 10.1111/jdv.16887. Epub 2020 Oct 1.
4
A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.一名44岁的西班牙裔男性，味觉丧失且双侧面部无力，被诊断为吉兰-巴雷综合征和贝尔麻痹，与SARS-CoV-2感染相关，接受静脉注射免疫球蛋白治疗。
Am J Case Rep. 2020 Oct 31;21:e927956. doi: 10.12659/AJCR.927956.
5
SARS-CoV-2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与炎症反应：从机制到静脉注射免疫球蛋白的潜在治疗用途
J Med Virol. 2021 May;93(5):2654-2661. doi: 10.1002/jmv.26651. Epub 2021 Feb 23.
6
Treatment of a case of COVID-19 by intravenous immunoglobulin.静脉注射免疫球蛋白治疗 1 例 COVID-19。
J Glob Antimicrob Resist. 2021 Mar;24:106-107. doi: 10.1016/j.jgar.2020.12.003. Epub 2020 Dec 24.
7
Acute COVID-19 Infection Associated With Necrotizing Disseminated Acute Leukoencephalopathy and Brain Microhemorrhages in a Pediatric Patient.儿童患者急性 COVID-19 感染相关的坏死性播散性急性脑白质病和脑微出血
Pediatr Infect Dis J. 2021 Dec 1;40(12):e493-e496. doi: 10.1097/INF.0000000000003302.
8
Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products.健康供体血浆库和静脉注射免疫球蛋白产品中的抗SARS-CoV-2抗体。
Lancet Infect Dis. 2021 Jun;21(6):765-766. doi: 10.1016/S1473-3099(21)00059-1. Epub 2021 Feb 16.
9
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children.儿童多系统炎症综合征心脏受累的评价。
Circulation. 2021 Jan 5;143(1):78-88. doi: 10.1161/CIRCULATIONAHA.120.049836. Epub 2020 Nov 9.
10
Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins manufactured from Post-COVID-19 and COVID-19-Vaccinated Plasma Donations.静脉注射用免疫球蛋白由新冠康复期及新冠疫苗接种者捐献的血浆制成，对 SARS-CoV-2 具有高效中和作用。
J Infect Dis. 2021 Nov 22;224(10):1707-1711. doi: 10.1093/infdis/jiab482.
引用本文的文献
1
Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients.静脉注射用免疫球蛋白（IVIG）在重症/危重症 COVID-19 成年患者中的应用。
Biomed Pharmacother. 2023 Jul;163:114851. doi: 10.1016/j.biopha.2023.114851. Epub 2023 May 5.
2
Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms.长期大剂量免疫球蛋白成功治疗有肺部、神经和心脏症状的长新冠患者。
Front Immunol. 2023 Feb 2;13:1033651. doi: 10.3389/fimmu.2022.1033651. eCollection 2022.
3
Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis.高剂量静脉注射免疫球蛋白对重症 COVID-19 患者死亡率的影响：一项更新的系统评价和荟萃分析。
Front Immunol. 2023 Jan 23;14:1116738. doi: 10.3389/fimmu.2023.1116738. eCollection 2023.
本文引用的文献
1
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.全球新型冠状病毒病 2019（COVID-19）后状况或长新冠的流行率：一项荟萃分析和系统评价。
J Infect Dis. 2022 Nov 1;226(9):1593-1607. doi: 10.1093/infdis/jiac136.
2
Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.解决 SARS-CoV-2 感染的后期后遗症：一种多学科的护理模式。
Lancet Respir Med. 2021 Nov;9(11):1328-1341. doi: 10.1016/S2213-2600(21)00385-4. Epub 2021 Oct 19.
3
Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years - Long Beach, California, April 1-December 10, 2020.成人 SARS-CoV-2 感染的急性后期效应 - 加利福尼亚州长滩，2020 年 4 月 1 日至 12 月 10 日。
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1274-1277. doi: 10.15585/mmwr.mm7037a2.
4
Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections.先天免疫在后持续性病毒感染的后遗症中的意义。
Cells. 2021 Aug 19;10(8):2134. doi: 10.3390/cells10082134.
5
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19.揭开 COVID-19 后急性后遗症之谜。
Front Immunol. 2021 Jun 30;12:686029. doi: 10.3389/fimmu.2021.686029. eCollection 2021.
6
Symptoms, complications and management of long COVID: a review.长新冠的症状、并发症及管理：综述。
J R Soc Med. 2021 Sep;114(9):428-442. doi: 10.1177/01410768211032850. Epub 2021 Jul 15.
7
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.长期新冠或新冠后急性后遗症（PASC）：可能导致持续症状的生物学因素概述
Front Microbiol. 2021 Jun 23;12:698169. doi: 10.3389/fmicb.2021.698169. eCollection 2021.
8
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.长期康复的 SARS-CoV-2 感染者中独特自身抗体的流行率。
J Autoimmun. 2021 Aug;122:102682. doi: 10.1016/j.jaut.2021.102682. Epub 2021 Jun 21.
9
The Conundrum of 'Long-COVID-19': A Narrative Review.“长新冠”难题：一篇叙述性综述
Int J Gen Med. 2021 Jun 14;14:2491-2506. doi: 10.2147/IJGM.S316708. eCollection 2021.
10
Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.确定严重急性呼吸综合征冠状病毒2感染后常见组织特异性自身抗体的流行情况。
Clin Exp Immunol. 2021 Aug;205(2):99-105. doi: 10.1111/cei.13623. Epub 2021 Jun 13.
Zotero 插件